Eli Lilly is working on a new GLP-1 drug, and early results suggest it could be a big winner.
REGIONS NEWS Revolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 ...
Doctronic reports that Foundayo, an oral GLP-1 for diabetes, shows promise but lacks long-term safety data beyond 68 weeks; ...
The survey was conducted by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London.
Prospective, multicenter trial will evaluate a novel preservation technique utilizing the SherpaPak ® for DCD (Donation afterCirculatoryDeath) hearts.
The synovial sarcoma clinical trial analysis report delivers important insights into ongoing research of 20+ pipeline ...
Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak ® for DCD (Donation after ...
OSF HealthCare has launched a new website on which it has listed openings for clinical trials for certain cancer patients. This new site offers search capability that allows people to learn what type ...
Advocate Health partners clinical trial matching by integrating Lind's AI platform into its EHR to improve cancer patient eligibility screening.
Experts noted that the study represents an important step toward generating scientific validation for traditional medicine ...
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results